Taraneh Matin, DO
Family Practice · Pasadena, CANPI 1528508876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 42.1% of the total. Reporting peaked in 2019 at $774 and has fallen 95.4% since, to $36 in 2025. Among family practice clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $41.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Bristol Myers Squibb$282
- E.r. Squibb & Sons, L.L.C.$265
- Regeneron Healthcare Solutions, Inc.$184
- Amgen$178
- Sun Pharmaceutical Industries Inc.$165
- plus $640 from 8 others
What the payments were for
- Speaking & faculty fees$803%
- Food & beverage$2,88197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $1,247 |
| Bristol Myers Squibb | 4 | $282 |
| E.r. Squibb & Sons, L.L.C. | 2 | $265 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| Amgen | 4 | $178 |
| Sun Pharmaceutical Industries Inc. | 3 | $165 |
| Galderma Laboratories, L.p. | 2 | $140 |
| Medtronic | 1 | $137 |
| UCB, Inc. | 2 | $130 |
| EPI Health, LLC | 1 | $80 |
| Lilly USA, LLC | 4 | $68 |
| Sanofi | 1 | $50 |
| Incyte Corporation | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,961 in reported general payments places this provider in the 95th percentile of 2,195 family practice providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 204 | $1,580 |
| Ketoconazole | 49 | $715 |
| Doxycycline Monohydrate | 61 | $490 |
| Triamcinolone Acetonide | 17 | $128 |
Paid to pharmacies, not to this prescriber.
Other family practice in Pasadena
- David CahnSan Jose$40K
- Linh NguyenSan Jose$15K
- Paige YoshisatoVallejo$14K
- Boris VaismanWoodland Hills$11K
- Sharon LaughlinRiverside$8K
- Michael KanLos Gatos$4K
- Claudia CarranzaBakersfield$4K
- Sunil HebbarHermosa Beach$3K
- Monica SuNewbury Park$3K
- Catherine ChernBurbank$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.